Sector: Pharmaceuticals & Biotechnology

Small Cap

Senores Pharmaceuticals Share Price

Senores Pharmaceuticals Ltd.

₹791.10

-19.20(-2.37%)

Trade Now

23rd Feb 2026 | 3:28 PM

NSE : SENORES

Open Free Demat Account

Senores Pharmaceuticals Performance

Price Movement

₹791.10

₹790.20

₹818.95

↘ Today's Low↗ Today's High

1 Year Performance

₹791.10

₹440.30

₹876.50

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹818.95

Low₹790.20

Open at₹807.10

Prev Close₹810.30

Volumes1.19 L

Avg Price₹798.47

Lower Circuit₹648.25

Upper Circuit₹972.35

Historical Performance

3M High₹876.50

3M Low₹738.10

1 Yr High₹876.50

1 Yr Low₹440.30

3 Yr High₹876.50

3 Yr Low₹435.25

5 Yr High₹876.50

5 Yr Low₹435.25

Senores Pharmaceuticals Fundamentals

Market Cap

Above industry Median

3,655.70 Cr.

PE Ratio (TTM)

Above industry Median

Dividend Yield

Net Profit TTM

65.0% incr over last year

101.60

Net Profit Growth

65.0% incr over last year

101.60

PEG Ratio

Above industry Median

0.60

ROE

52% decr over last year

7.44

Operating Revenue TTM

588.52

Operating Revenue Growth

40.5% incr over last year

Book Value

Above industry Median

4.50

MFI

MFI Overbought

75.85

RSI

RSI is mid-range

50.49

EPS (TTM)

16.12

Debt to Equity

0.39

Face Value

Operating Profit Margin Qtr.

21.48

Operating Profit Qtr.

54.01

Net Profit Qtr.

31.66

Operating Revenue Qtr.

174.56

PB Ratio

4.50

Senores Pharmaceuticals Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Revenue	28.76	35.33	19.82	11.86	9.59
Operating Expense	29.69	33.81	20.97	14.60	12.01
Operating Profit	-0.93	1.52	-1.15	-2.74	-2.42
Depreciation	3.58	3.65	1.88	1.27	0.75
Interest	1.75	1.58	1.76	2.35	2.70
Tax	0.87	1.22	0.90	0.88	0.25
Net Profit	2.65	6.43	2.70	2.01	1.07

Senores Pharmaceuticals Technicals

Senores Pharmaceuticals Ltd. EMA & SMA

₹791.10

-19.20 (-2.37%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹810

Day EMA10 ₹809.1

Day EMA12 ₹809

Day EMA20 ₹809

Day EMA26 ₹808.9

Day EMA50 ₹804.1

Day EMA100 ₹778.7

Day EMA200 ₹713.4

Senores Pharmaceuticals Support and Resistance

Resistance

First Resistance₹817.70

Second Resistance₹825.10

Third Resistance₹831.30

Support

First Support₹804.10

Second Support₹797.90

Third Support₹790.50

Technical Indicators

Day RSI50.49

Day MFI75.85

Day ADX11.75

Day Commodity Channel Index19.30

William-50.91

Day MACD0.16

Day MACD Signal Line-0.12

Day ATR28.53

Day ROC12516.03

Day ROC21-3.32

Senores Pharmaceuticals Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoter	45.8	45.8	45.8	45.8	45.8
FII	4.2	4.2	3.7	4.3	3.4
DII	11.8	9.6	9.5	8.6	9.3
Public	38.2	40.4	41	41.3	41.5

Senores Pharmaceuticals Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	42.09 K	79.38 K	53.02%
Week	1.03 L	1.93 L	53.45%
1 Month	77.36 K	1.59 L	48.67%
6 Month	1.37 L	3.05 L	44.90%

Senores Pharmaceuticals SWOT Analysis

Strengths20

Weakness11

Opportunity5

Threats0

Benjamin Graham Value Screen

Strong Performer, Getting Expensive (DVM)

Consistent high performing stocks over Five Years

Relative Outperformance versus Industry over 1 Year

Companies with high TTM EPS Growth

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Good quarterly growth in the recent results

Relative Outperformance versus Industry over 1 Week

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Companies with reducing Debt

Increasing Revenue every Quarter for the past 4 Quarters

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Recent Results : Growth in Operating Profit with increase in operating margins (YoY)

Stocks near 52 Week High with Significant Volumes

Stocks Outperforming their Industry Price Change in the Quarter

Senores Pharmaceuticals Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

Senores Pharmaceuticals Stock Comparison

Financials	Vivimed Labs Ltd.	Amanta Healthcare Ltd.	Anlon Healthcare Ltd.	Amrutanjan Health Care Ltd.	Innova Captab Ltd.
Price (₹)	₹8.43	₹104	₹115.35	₹604	₹690
% Change	4.98%	-1.38%	-3.98%	-1.99%	3.06%
Revenue TTM (₹ Cr)	₹104.12	₹282.74	-	₹488.20	₹1,496.96
Net Profit TTM (₹ Cr)	₹-24.37	₹15.30	-	₹56.90	₹132.41
PE TTM	-2.90	26.50	-	30.70	29.60
1 Year Return	743	-17.19	27.77	0.89	-12.8
ROCE	-5.63	-	-	23.87	14.12

Similar Stocks

VALIANTLAB

Valiant Laboratories Ltd.

₹ 59.10

+1.37%

SIGACHI

Sigachi Industries Ltd.

₹ 21.22

-3.68%

WINDLAS

Windlas Biotech Ltd.

₹ 774.00

-0.82%

VINEETLAB

Vineet Laboratories Ltd.

₹ 31.51

-1.62%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 472.60

+0.23%

ZIMLAB

Zim Laboratories Ltd.

₹ 72.00

+1.72%

MEDICO

Medico Remedies Ltd.

₹ 48.00

+4.53%

DCAL

Dishman Carbogen Amcis Ltd.

₹ 182.40

+0.07%

LASA

Lasa Supergenerics Ltd.

₹ 8.05

+2.42%

ADVENZYMES

Advanced Enzyme Technologies Ltd.

₹ 313.00

+0.02%

BAJAJHCARE

Bajaj Healthcare Ltd.

₹ 348.00

-1.29%

ORTINGLOBE

Ortin Global Ltd.

₹ 18.91

-4.97%

BROOKS

Brooks Laboratories Ltd.

₹ 72.62

-2.48%

RPGLIFE

RPG Life Sciences Ltd.

₹ 1915.00

+0.59%

BAFNAPH

Bafna Pharmaceuticals Ltd.

₹ 111.50

-1.11%

ALPA

Alpa Laboratories Ltd.

₹ 68.45

+2.30%

SPARC

Sun Pharma Advanced Research Company Ltd.

₹ 127.75

-1.13%

SMSPHARMA

SMS Pharmaceuticals Ltd.

₹ 375.20

+0.74%

NECLIFE

Nectar Lifesciences Ltd.

₹ 12.70

+0.63%

MANGALAM

Mangalam Drugs and Organics Ltd.

₹ 31.15

-1.61%

INDOCO

Indoco Remedies Ltd.

₹ 200.10

+0.93%

INDSWFTLAB

Ind-Swift Laboratories Ltd.

₹ 146.60

+3.32%

LINCOLN

Lincoln Pharmaceuticals Ltd.

₹ 619.00

-0.58%

PANACEABIO

Panacea Biotec Ltd.

₹ 338.80

-0.79%

FAQ's on SENORES

What is the current share price of Senores Pharmaceuticals Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Senores Pharmaceuticals Ltd. is ₹ 791.1 on the NSE and ₹ 792 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Senores Pharmaceuticals Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Senores Pharmaceuticals Ltd. is approximately ₹ 3655.7 Cr.

What are the PE and PB ratios for Senores Pharmaceuticals Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Senores Pharmaceuticals Ltd. is 36, and the Price-to-Book (PB) ratio is 4.5.

What is the 52-Week High and Low for Senores Pharmaceuticals Ltd.?

Over the past 52 weeks, the highest price reached by Senores Pharmaceuticals Ltd. shares was ₹ 876.5, and the lowest price was ₹ 440.3.

Who are the major shareholders of Senores Pharmaceuticals Ltd.?

Significant shareholdings in Senores Pharmaceuticals Ltd. typically include entities such as:

Promoter
Public
Mutual Funds
Other Institutions
FII

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Senores Pharmaceuticals Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Senores Pharmaceuticals Ltd. is often compared with other major players such as Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs, Corona Remedies, Sudeep Pharma and Curis Lifesciences for analysis and benchmarking.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy